Angiodynamics Inc (ANGO)

R&D Expenses

$7.98M

Quarterly · Period ending: · USD

ANGO logo

ANGO R&D Expenses

Latest reported$7.98M
ANGO Quarterly R&D Expenses ($0.00 → $7.98M)
High-resolution chart · PNG

ANGO r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Angiodynamics Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
7,979,000
8,178,000
7,084,000
7,768,000
6,417,000
6,590,000
6,913,000
6,434,000
6,285,000
6,724,000
8,189,000
8,658,000
7,941,000
7,860,000
6,852,000
6,838,000
8,333,000
7,866,000
7,280,000
8,199,000
7,394,000
9,104,000
8,565,000
9,712,000
9,009,000
7,232,000
8,395,000
7,764,000
6,292,000
7,200,000
7,210,000
7,363,000
7,662,000
6,454,000
6,457,000
6,107,000
6,441,000
6,696,000
5,951,000
5,913,000
6,709,000
6,937,000
5,808,000
6,179,000
6,202,000
7,289,000
6,855,000
6,069,000
6,718,000
6,753,000
7,045,000
7,003,000
6,709,000
6,438,000
5,793,000
7,014,000
7,074,000
5,222,000
4,574,000
5,125,000
5,591,000
5,549,000
5,322,000
5,259,000
5,242,000
5,374,000
4,289,000
4,763,000
4,849,000
4,835,000
4,692,000
4,425,000
3,962,000
4,064,000
3,955,000
3,694,000
2,711,000
3,043,000
14,248,000
1,637,000
1,627,000
1,359,000
1,446,000
1,545,000
1,519,000
1,294,000
1,026,000
1,122,000
1,128,000
954,000
866,000
740,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.